|
CSNK2A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.15239945258838E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53265999999208E-05 |
| Normal-vs-Stage2 |
3.218100E-03 |
| Normal-vs-Stage3 |
2.237500E-04 |
| Normal-vs-Stage4 |
1.511860E-02 |
| Stage1-vs-Stage2 |
3.328800E-01 |
| Stage1-vs-Stage3 |
2.097600E-02 |
| Stage1-vs-Stage4 |
7.637900E-02 |
| Stage2-vs-Stage3 |
1.690610E-01 |
| Stage2-vs-Stage4 |
3.926200E-01 |
| Stage3-vs-Stage4 |
7.602000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29919996982863E-09 |
| Normal-vs-AfricanAmerican |
3.415000E-04 |
| Normal-vs-Asian |
1.061250E-01 |
| Caucasian-vs-AfricanAmerican |
7.229600E-01 |
| Caucasian-vs-Asian |
2.359400E-01 |
| AfricanAmerican-vs-Asian |
2.239000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61839999682323E-08 |
| Normal-vs-Female |
2.38549999975746E-07 |
| Male-vs-Female |
5.749800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.136420E-03 |
| Normal-vs-Extreme_Weight |
4.23310000000621E-05 |
| Normal-vs-Obese |
2.91500000004774E-06 |
| Normal-vs-Extreme_Obese |
2.283000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.479800E-01 |
| Normal_Weight-vs-Obese |
1.632590E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.047200E-01 |
| Extreme_Weight-vs-Obese |
7.714200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.502400E-01 |
| Obese-vs-Extreme_Obese |
3.014200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.020820E-03 |
| Normal-vs-Age(41-60Yrs) |
1.12400000418234E-08 |
| Normal-vs-Age(61-80Yrs) |
1.60979999996869E-06 |
| Normal-vs-Age(81-100Yrs) |
2.104800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.002400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.203800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.840700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.292600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.774420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.060200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.6425999983567E-08 |
| Normal-VS-Type2 PRCC |
9.77260000000202E-05 |
| Normal-VS-KIRP CIMP |
9.614100E-04 |
| Normal-VS-Unclassified PRCC |
3.385100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.616600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.863200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.821800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.89670000000564E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.523000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.392900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.399800E-03 |
| Normal-vs-N1 |
7.89440000000807E-05 |
| Normal-vs-N2 |
9.770200E-02 |
| N0-vs-N1 |
5.061900E-02 |
| N0-vs-N2 |
1.831350E-01 |
| N1-vs-N2 |
6.807200E-01 |
|
|
